Kronos Bio Stock Probability of Future Stock Price Finishing Over 11.96
| KRON Stock | USD 0.94 0.02 2.17% |
Kronos |
Kronos Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kronos Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kronos Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kronos Bio generated a negative expected return over the last 90 days | |
| Kronos Bio has some characteristics of a very speculative penny stock | |
| Kronos Bio has high historical volatility and very poor performance | |
| Kronos Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.29 M. Net Loss for the year was (112.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kronos Bio currently holds about 267.89 M in cash with (78.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders |
Kronos Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kronos Stock often depends not only on the future outlook of the current and potential Kronos Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kronos Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.7 M | |
| Cash And Short Term Investments | 173 M |
Kronos Bio Technical Analysis
Kronos Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Kronos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kronos Bio. In general, you should focus on analyzing Kronos Stock price patterns and their correlations with different microeconomic environments and drivers.
Kronos Bio Predictive Forecast Models
Kronos Bio's time-series forecasting models is one of many Kronos Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kronos Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Kronos Bio
Checking the ongoing alerts about Kronos Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kronos Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Kronos Bio generated a negative expected return over the last 90 days | |
| Kronos Bio has some characteristics of a very speculative penny stock | |
| Kronos Bio has high historical volatility and very poor performance | |
| Kronos Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.29 M. Net Loss for the year was (112.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kronos Bio currently holds about 267.89 M in cash with (78.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders |
Check out Kronos Bio Backtesting, Kronos Bio Valuation, Kronos Bio Correlation, Kronos Bio Hype Analysis, Kronos Bio Volatility, Kronos Bio History as well as Kronos Bio Performance. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.